Evidence map›Paper›PMID 39039405›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Detection and Diagnosis of Rift Valley Fever Virus.

Ndeye Sakha Bob, Moussa Dia, Oumar Ndiaye, Arame Ba, Julie Prudhomme, Moussa Moise Diagne, Oumar Faye, Ousmane Faye, Amadou Alpha Sall, Gamou Fall

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ndeye Sakha BobVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Moussa DiaVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Oumar NdiayeVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Arame BaVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Julie PrudhommeVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Moussa Moise DiagneVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Oumar FayeVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Ousmane FayeVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Amadou Alpha SallVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal.
Gamou FallVirology Pole-WHO collaborating Center for Arbovirus and viral hemorrhagic fevers, Institut Pasteur de Dakar, Dakar, Senegal. gamou.fall@pasteur.sn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rift Valley fever virus (RVFV) is a globally important mosquito-borne virus that can also be directly transmitted via aerosolization of body fluids from infected animals. RVFV outbreaks cause mass mortality of young livestock and abortions in animals. In most severe human cases, the disease can progress to hemorrhagic fever and encephalitis, leading to death. RVF has a significant economic impact due to the loss of livestock that is a great challenge for people who depend on animals for income and food. Several vaccines are available for animal use, but none are yet licensed for use in human populations. This situation emphasizes the need to have robust and efficient diagnostic methods that can be used for early case confirmation, assessment of seroprevalence, and virus surveillance as well as vaccine efficacy evaluation. Despite the existence of different diagnostic methods for RVFV, we still have untimely reporting or underreporting of cases, probably due to lack of appropriate surveillance systems or diagnostic tools in some endemic countries. Here, we describe different methods available for detection and diagnosis of RVFV.

Indexed as

Rift Valley FeverRift Valley fever virusAnimalsAntibodies, ViralEnzyme-Linked Immunosorbent AssayHumansAntibodies, ViralDetectionDiagnosisELISAHistopathologyRDTsRift Valley fever virusRT-PCRSequencingSeroneutralization

Identifiers

PMID39039405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.